Literature DB >> 21144916

Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac Initiative.

Barbara Jauregui1, Anushua Sinha, Andrew D Clark, Brenda M Bolanos, Stephen Resch, Cristiana M Toscano, Cuauhtemoc Ruiz Matus, Jon K Andrus.   

Abstract

Rotavirus, pneumococcal conjugate and HPV vaccines have the potential to make substantial gains in health, specifically in reducing child mortality and improving women's health. Decisions regarding new vaccine introduction should be grounded in a broad evidence base that reflects national conditions. In this paper, we describe the Pan American Health Organization ProVac Initiative's experience in strengthening national decision making regarding new vaccine introduction through five sets of activities: (1) strengthening infrastructure for decision making; (2) developing tools for economic analyses and providing training to national multidisciplinary teams; (3) collecting data, conducting analysis, and gathering a framework of evidence; (4) advocating for evidence-based decisions; and (5) effectively planning for new vaccine introduction when evidence supports it. Key lessons learned regarding the role of multidisciplinary country teams, provision of direct technical support, development of tools, and provision of distance and in-person training are highlighted. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21144916     DOI: 10.1016/j.vaccine.2010.11.075

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Bolivian health providers' attitudes toward alternative technologies for cervical cancer prevention: a focus on visual inspection with acetic acid and cryotherapy.

Authors:  Analía Romina Stormo; Victor Conde Altamirano; Macarena Pérez-Castells; David Espey; Haydee Padilla; Karen Panameño; Milton Soria; Carlos Santos; Mona Saraiya; Silvana Luciani
Journal:  J Womens Health (Larchmt)       Date:  2012-07-20       Impact factor: 2.681

2.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

3.  Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh.

Authors:  Abdur Razzaque Sarker; Marufa Sultana; Rashidul Alam Mahumud; Robert Van Der Meer; Alec Morton
Journal:  Hum Vaccin Immunother       Date:  2017-12-12       Impact factor: 3.452

4.  Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal.

Authors:  Raymond Hutubessy; Ana Maria Henao; Pem Namgyal; Vasee Moorthy; Joachim Hombach
Journal:  BMC Med       Date:  2011-05-12       Impact factor: 8.775

5.  Stakeholders' perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study.

Authors:  Ingeborg M van der Putten; Silvia M A A Evers; Rohan Deogaonkar; Mark Jit; Raymond C W Hutubessy
Journal:  BMC Public Health       Date:  2015-04-10       Impact factor: 3.295

6.  Key actors' perspectives on cost-effectiveness analysis in Uganda: a cross-sectional survey.

Authors:  Jackson S Musuuza; Mendel E Singer; Anna M Mandalakas; Achilles Katamba
Journal:  BMC Health Serv Res       Date:  2014-11-04       Impact factor: 2.655

7.  Institutional capacity to generate and use evidence in LMICs: current state and opportunities for HPSR.

Authors:  Zubin Cyrus Shroff; Dena Javadi; Lucy Gilson; Rockie Kang; Abdul Ghaffar
Journal:  Health Res Policy Syst       Date:  2017-11-09

8.  Development of a cholera vaccination policy on the Island of Hispaniola, 2010-2013.

Authors:  Andrea S Vicari; Cuauhtémoc Ruiz-Matus; Ciro de Quadros; Jon K Andrus
Journal:  Am J Trop Med Hyg       Date:  2013-10       Impact factor: 2.345

9.  Modeling the public health impact of malaria vaccines for developers and policymakers.

Authors:  Julia K Nunes; Vicky Cárdenas; Christian Loucq; Nicolas Maire; Thomas Smith; Craig Shaffer; Kårstein Måseide; Alan Brooks
Journal:  BMC Infect Dis       Date:  2013-07-01       Impact factor: 3.090

Review 10.  Challenges in the research and development of new human vaccines.

Authors:  T Barbosa; M Barral-Netto
Journal:  Braz J Med Biol Res       Date:  2013-02       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.